EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Percutaneous Insertion of Hepatic Arterial Infusion Ports by Interventional Radiology for Colorectal Liver Metastases

Hugo C Temperley iD, Omar Abu Saadeh iD, Padraig Cronin, Cormac B Mulhall iD, Niall J O'Sullivan iD, Benjamin M Mac Curtain, Alice Talbot, Emily Harrold, David Gallagher, Michael E Kelly iD, Hooman Yarmohammadi, Vlasios S Sotirchos iD

Cancers · 29.10.2026 · 18 (21) · 3495

DOI: 10.3390/cancers18213495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.10.2026. Verfasst von Hugo C Temperley und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, St James's Hospital, D08 NHY1 Dublin, Ireland. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic arterial infusion (HAI) chemotherapy for colorectal liver metastases (CRLM) is delivered through a port–catheter system implanted percutaneously by interventional radiology or surgically. Previous studies have pooled device complications across access methods as event counts, but have not synthesised the technical performance and durability of fully percutaneous insertion at the patient level.

Methods

Medline, EMBASE, Cochrane Library, Scopus and Web of Science were searched for studies published from 2000 onward reporting adults with CRLM undergoing HAI port insertion. Primary analyses were restricted to fully percutaneous implanted ports, using outcome-specific, patient-level numerators and denominators; a study using surgical arterial cutdown was added in sensitivity analyses. Risk of bias in the device outcomes was assessed at item level for patient selection, completeness of data, outcome ascertainment and selective reporting, with Cochrane RoB 2 used additionally for the single randomised trial. Random-effects proportion meta-analyses used the Freeman–Tukey double arcsine transformation and the DerSimonian–Laird estimator, with a binomial generalised linear mixed model (GLMM) as an alternative. Outcomes with inconsistent definitions or denominators were synthesised narratively.

Results

Fifteen studies contributed 811 patients, 654 of whom underwent percutaneous insertion. One study was randomised, five prospective and nine retrospective; three reported a surgical comparator arm. Risk of bias in the device outcomes was low in one study, moderate in six and high in eight. Eleven studies (423 patients) of fully percutaneous implanted ports contributed to the primary analyses. Technical success was reported explicitly by eight and achieved in 276 of 278 patients (99.3%, exact 95% CI 97.4–99.9%); with only two failures, pooled models added little. Device-attributable definitive failure, meaning permanent discontinuation of HAI because of the device, occurred in 39 of 374 patients (crude 10.4%) over observation periods that varied widely; the random-effects estimate was 6.9% (95% CI 2.1–13.7%; I2 = 74.5%; GLMM 6.9%, 3.0–15.2%), and 11.6% (95% CI 6.3–18.0%) in the six studies at low or moderate risk of bias. Catheter dislodgement affected a pooled 5.8% (95% CI 1.6–11.6%), and 14.8% where the port was checked angiographically before every course or every four weeks; hepatic arterial occlusion affected 3.4% (95% CI 0.9–7.0%; four studies). Revision was required in 56% and 59% of percutaneous patients in the two series reporting it.

Conclusions

Percutaneous insertion of HAI ports rarely failed technically in these series, but reintervention was common and permanent loss of HAI to a device problem within the follow-up reported was estimated at 6.9% in the primary analysis and 11.6% in studies at lower risk of bias, with more problems detected where the device was monitored more closely. Catheter-tip technique, follow-up duration and intensity of device surveillance are possible, unproven contributors to heterogeneity. These predominantly observational data support the feasibility of percutaneous access, not patient suitability for HAI chemotherapy.

Schlagwörter

Stichwörter der Autor:innen

colorectal liver metastasesdevice failurehepatic arterial infusioninterventional radiologymeta-analysispercutaneous implantationport–catheter systemtechnical success

Autor:innen und Institutionen

  • Department of Radiology, St James's Hospital, D08 NHY1 Dublin, Ireland.
  • Trinity St James Cancer Institute, St James's Hospital, D08 NHY1 Dublin, Ireland.
  • Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
  • Department of Surgery, Cork University Hospital, T12 DC4A Cork, Ireland.
  • Department of General Surgery, Royal Perth Hospital, Perth, WA 6000, Australia.
  • Northwell Health, New Hyde Park, NY 11040, USA.

ORCID-Profile: Hugo C Temperley, Omar Abu Saadeh, Cormac B Mulhall, Niall J O'Sullivan, Michael E Kelly, Vlasios S Sotirchos

Zitieren

APA

Temperley, H. C., Saadeh, O. A., Cronin, P., Mulhall, C. B., O'Sullivan, N. J., Mac Curtain, B. M., Talbot, A., Harrold, E., Gallagher, D., Kelly, M. E., Yarmohammadi, H., & Sotirchos, V. S. (2026). Percutaneous Insertion of Hepatic Arterial Infusion Ports by Interventional Radiology for Colorectal Liver Metastases. Cancers, 18(21), 3495. https://doi.org/10.3390/cancers18213495

Vancouver

Temperley HC, Saadeh OA, Cronin P, Mulhall CB, O'Sullivan NJ, Mac Curtain BM, et al. Percutaneous Insertion of Hepatic Arterial Infusion Ports by Interventional Radiology for Colorectal Liver Metastases. Cancers. 2026;18(21):3495. doi:10.3390/cancers18213495

BibTeX
@article{Temperley2026,
  author = {Temperley, Hugo C and Saadeh, Omar Abu and Cronin, Padraig and Mulhall, Cormac B and O'Sullivan, Niall J and Mac Curtain, Benjamin M and Talbot, Alice and Harrold, Emily and Gallagher, David and Kelly, Michael E and Yarmohammadi, Hooman and Sotirchos, Vlasios S},
  title = {Percutaneous Insertion of Hepatic Arterial Infusion Ports by Interventional Radiology for Colorectal Liver Metastases},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3495},
  doi = {10.3390/cancers18213495}
}
Kostenlos starten →